| Bioactivity | Pendetide is a chelating agent, can be conjugated with Indium (111In) Capromab for further diagnostic use. Capromab pendetide is a FDA-approved imaging agent for the detection of soft tissue metastases in prostate carcinoma[1]. |
| Target | a?chelating agent, can be conjugated with Indium (111In) capromab for further diagnostic use.；?https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.10337；NIH药物肽，袁子琛要求上线，2023/11/4 |
| Name | Pendetide |
| CAS | 148805-91-8 |
| Sequence | Gly-Tyr-Lys-DTPA |
| Shortening | GYK-DTPA |
| Formula | C31H47N7O14 |
| Molar Mass | 741.74 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ganesh V Raj, et al. Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy. Cancer. 2002 Feb 15;94(4):987-96. |
Pendetide
CAS: 148805-91-8 F: C31H47N7O14 W: 741.74
Pendetide is a chelating agent, can be conjugated with Indium (111In) Capromab for further diagnostic use. Capromab pend
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.